Crestor (rosuvastatin) encapsulated tablet
Sponsors
AstraZeneca AB
Conditions
Hypercholesterolaemia
Phase 3
A Phase III Randomised, Double-Blind, Parallel-Group Study to Assess the Effect of Fixed Dose Combination Laroprovstat/Rosuvastatin Compared with Rosuvastatin on Low-Density Lipoprotein Cholesterol in Patients with Hypercholesterolaemia.
Not yet recruitingCTIS2026-526258-15-00
Target: 60Updated: 2026-08-17
A Phase III Randomised, Double-Blind, Factorial Design Study to Assess the Effect of Fixed Dose Combination Laroprovstat/Rosuvastatin compared with Laroprovstat, Rosuvastatin, and Placebo on Low-Density Lipoprotein Cholesterol in Lipid-Lowering Treatment-Naïve Patients
Not yet recruitingCTIS2026-525642-30-00
Target: 145Updated: 2026-10-06